close

FDA Updates

FDA Updates

Recent FDA Approvals

Calquence Approved for Mantle Cell Lymphoma Yescarta CAR T-Cell Therapy Approved for Large B-Cell Lymphoma Aliqopa Approved for Adults with Relapsed Follicular Lymphoma Actemra First FDA-Approved Treatment for CAR T-Cell–Induced [ Read More ]

FDA Updates

Pembrolizumab Approved as First Cancer Treatment Based on Biomarkers

The FDA has granted accelerated approval to pembrolizumab for the treatment of any solid tumor in the body with a specific genetic feature, or biomarker. Until now, FDA approval for [ Read More ]

FDA Updates

FDA Approves Maintenance Treatment for Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary [ Read More ]